Bibliography
- Reimer P , TombachB: Hepatic MRI with SPIO: detection and characterization of focal liver lesions.Eur. Radiol.8, 1198–1204 (1998).
- Waters EA , WicklineSA: Contrast agents for MRI.Basic Res. Cardiol.103, 114–121 (2008).
- Rohrer M , BauerH, MintorovitchJet al.: Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.Invest. Radiol.40, 715–724 (2005).
- Werner EJ , DattaA, JocherCJ, RaymondKN: High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.Angew. Chem. Int. Ed.47, 8568–8580 (2008).
- Tombach B , ReimerP: Soluble paramagnetic chelates and stabilized colloidal particle solutions of iron oxides as contrast agents for magnetic resonance imaging.Curr. Med. Chem.12, 2795–2804 (2005).
- Corot C , ViolasX, RobertP, GagneurG, PortM: Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.Invest. Radiol.38, 311–319 (2003).
- Bremerich J , BilecenD, ReimerP: MR angiography with blood pool contrast agents.Eur. Radiol.17, 3017–3024 (2007).
- Misselwitz B , Schmitt-WillichH, EbertW, FrenzelT, WeinmannHJ: Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent.MAGMA12, 128–134 (2001).
- Ergun I , KevenK, UrucIet al.: The safety of gadolinium in patients with stage 3 and 4 renal failure.Nephrol. Dial. Transplant.21, 697–700 (2006).
- Kuo PH , Abu-AlfaA, BucalaRet al.: MRI in the era of nephrogenic systemic fibrosis: review, controversies and suggestions for risk reduction.Appl. Radiol.38, 22–33 (2009).
- Tartaj P , del Puerto Morales M, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ: The preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys.36, R182–R197 (2003).
- Weissleder R , StarkDD, EngelstadBLet al.: Superparamagnetic iron oxide: pharmacokinetics and toxicity.AJR Am. J. Roentgenol.152, 167–173 (1989).
- Magnani M , GalluzziL, BruceIJ: The use of magnetic nanoparticles in the development of new molecular detection systems.J. Nanosci. Nanotechnol.6, 2302–2311 (2006).
- Veiseh O , GunnJW, ZhangM: Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Adv. Drug Deliv. Rev.62, 284–304 (2009).
- Wang YX , HussainSM, KrestinGP: Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.Eur. Radiol.11, 2319–2331 (2001).
- Morana G , SalviatoE, GuariseA: Contrast agents for hepatic MRI.Cancer Imaging7, S24–S27 (2007).
- Reimer P , BalzerT: Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.Eur. Radiol.13, 1266–1276 (2003).
- Simon GH , RaatschenHJ, WendlandMFet al.: Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research.Acad. Radiol.12, 1190–1197 (2005).
- Berry CC , CurtisASG: Functionalisation of magnetic nanoparticles for applications in biomedicine.J. Physics D Appl. Physics36, R198–R206 (2003).
- Gindy ME , Prud‘hommeRK: Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.Expert Opin. Drug Deliv.6, 865–878 (2009).
- Sun C , LeeJSH, ZhangM: Magnetic nanoparticles in MR imaging and drug delivery.Adv. Drug Deliv. Rev.60, 1252–1265 (2008).
- Allkemper T , BremerC, MatuszewskiL, EbertW, ReimerP: Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits.Radiology223, 432–438 (2002).
- Lee JH , HuhYM, JunYW, SeoJW, JangJT, SongHT: Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging.Nat. Med.13, 95–99 (2007).
- Rossi L , SerafiniS, PierigéFet al.: Erythrocyte-based drug delivery.Expert Opin. Drug Deliv.2, 311–322 (2005).
- Antonelli A , SfaraC, MoscaL, ManualiE, MagnaniM: New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles.J. Nanosci. Nanotechnol.8, 2270–2278 (2008).
- Sen T , MagdassiS, NizriG, BruceIJ: Dispersion of magnetic nanoparticles in suspension.Micro. Nano. Lett.1, 39–42 (2006).
- Bruce IJ , SenT: Surface modification of magnetic nanoparticles with alkoxysilanes and their application in magnetic bioseparations.Langmuir21, 7029–7035 (2005).
- Del Campo A , SenT, LelloucheJP, BruceIJ: Multifunctional magnetite and silica-magnetite nanoparticles: synthesis, surface activation and applications in life sciences.J. Magn. Magn. Mater.293, 33–40 (2005).
- Casula MF , FlorisP, InnocentiCet al.: Magnetic resonance imaging contrast agents based on iron oxide superparamagnetic ferrofluidsChem. Mater.22, 1739–1748 (2010).
- Bruce IJ , TaylorJ, ToddMet al.: Synthesis, characterisation and application of silica-magnetite nanocomposites.J. Magn. Magn. Mater.284, 145–160 (2004).
- Massart R , DuboisE, CabuilV, HasmonayE: Preparation and properties of monodisperse magnetic fluids.J. Magn. Magn. Mater149, 1–5 (1995).
- Lin CL , LeeCF, ChiuWY: Preparation and properties of poly(acrylic acid) oligomer stabilized superparamagnetic ferrofluid.J. Colloid Interface Sci.29, 411–420 (2005).
- Casula MF , CorriasA, ArosioPet al.: Design of water-based ferrofluids as contrast agents for magnetic resonance imaging.J. Colloid Interface Sci. doi: 10.1016/j.jcis.2011.01.088 (2011) (Epub ahead of print).
- Gadian DG : Nuclear Magnetic Resonance and its Applications to Living Systems. The Alden Press Ltd, Oxford, UK (1984).
- Carr HY , PurcellEM: Effects of diffusion on free precession in nuclear magnetic resonance experiments.Phys. Rev.94, 630–638 (1954).
- Meiboom S , GillD: Modified spin-echo method for measuring nuclear relaxation times.Rev. Sci. Instruments29, 688–691 (1958).
- Markov D , BoeveH, GleichBet al.: Human erythrocytes as nanoparticle carriers for magnetic particle imaging.Phys. Med. Biol.55(21), 6461–6473 (2010).
- Brähler M , GeorgievaR, BuskeNet al.: Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging.Nano Lett.6(11), 2505–2509 (2006).